Our editorial approach
We synthesise peer-reviewed research, registry data, official guidance, and clinical trial summaries to produce plain-language briefings. Our summaries emphasize safety concerns, screening protocols, and realistic expectations for people considering ibogaine-related care. Where helpful, we link to network pages about access and models rather than offering treatment endorsements; for example, some readers review regional program descriptions such as state-level information on treatment options in Texas when they want context about legal research pathways.
How we source and vet information
Our editorial process begins with systematic searches of published literature and clinical registries, followed by triage of evidence quality and risk factors. We prioritise randomized clinical trials, cohort studies, and authoritative reviews, and we clearly mark when material is anecdotal or based on observational reports.
To ground methodology claims we reference high-level authoritative sources such as government guidance on substance use and treatment frameworks (for example, public health summaries from NIH/NLM) and encyclopedic descriptions (see ibogaine on Wikipedia) when noting historic context or pharmacology at a conceptual level.
What we cover
- Evidence summaries and notable research studies relevant to stimulant use and addiction treatment.
- Safety and screening practices, with emphasis on cardiovascular risk factors and medical supervision.
- Practical considerations around legal status and access models, including regulated programs and cross-border care.
- Aftercare, integration strategies, and harm-reduction guidance that supports recovery goals.
Who this is for
This resource is targeted to people living with stimulant use disorder and those supporting them — family, friends, and community health workers seeking clear, unbiased information. If you are looking for a clinic or a treatment referral, we encourage you to prioritise providers who publish transparent screening protocols and confirm on-site medical supervision by qualified medical professionals.
Editorial principles
- Independence — no clinic endorsements or sponsored treatment listings.
- Plain language — translate technical research into actionable summaries for non‑specialists.
- Evidence-first — prioritise higher-quality scientific research and clearly label anecdotal data.
- Audience-focused — centre the concerns of people living with stimulant use disorder and their support networks.
We also cross-link to related pages in our network when readers need practical access information; for example, people exploring treatment centers sometimes consult regional directories such as Mexico clinic directories to compare regulated access models.
To see how our content is used in practice and what services are described in the network, visit our brief overview of program types on the services page.
Related network pages & reading
We host practical pages and link to informational resources in our network. For example, if you are exploring where treatments are offered under medical oversight, many people review descriptive pages such as state program descriptions for Texas and international directories like Mexico clinic listings. These network pages are maintained by independent operators and are presented here only for context.
For technical chemistry or HCl-specific discussion used by clinicians and chemists, readers sometimes consult specialist summaries such as ibogaine HCl information. For broader background on what a course of care typically involves, overview pages like what an ibogaine treatment involves can be helpful starting points.
Community-maintained reviews of stimulant outcomes are also cited in our research pages; one such synthesis is available at ibogaine.wiki's stimulant-addiction summary.
